Novocure (NVCR) Tops Q4 EPS by 19c ; Offers Guidance

Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.22), $0.19 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $174.35 million versus the consensus estimate of $168.31 million.

GUIDANCE:

Novocure sees FY2026 revenue of $675-705 million, versus the consensus of $681.2 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• XP Inc. (XP) Tops Q2 EPS by 8c
• Rocket Lab joins U.S. Space Force's $981M NITE-STAR contract